Serogroup/type, order of frequency | All participantsab | Patientsb | Healthy controls | p-valuec |
---|---|---|---|---|
(n = 809) | (n = 648) | (n = 161) | Patients vs controls | |
6A/B/C/D | 143 (18%) | 115 (18%) | 28 (17%) | 1.000 |
19F | 98 (12%) | 86 (13%) | 12 (7%) | 0.043 |
19A | 45 (6%) | 38 (6%) | 7 (4%) | 0.566 |
14 | 44 (5%) | 39 (6%) | 5 (3%) | 0.175 |
23F | 31 (4%) | 25 (4%) | 6 (4%) | 1.000 |
15BC | 30 (4%) | 24 (4%) | 6 (4%) | 1.000 |
11 | 29 (4%) | 25 (4%) | 4 (2%) | 0.486 |
7C | 15 (2%) | 14 (2%) | 1 (1%) | 0.327 |
5 | 12 (1%) | 11 (2%) | 1 (1%) | 0.477 |
10A | 12 (1%) | 10 (2%) | 2 (1%) | 1.000 |
9A/V | 9 (1%) | 8 (1%) | 1 (1%) | 1.000 |
18 | 7 (1%) | 5 (1%) | 2 (1%) | 0.631 |
12 | 7 (1%) | 7 (1%) | 0 (0%) | 0.356 |
3 | 7 (1%) | 6 (1%) | 1 (1%) | 1.000 |
20 | 5 (1%) | 4 (1%) | 1 (1%) | 1.000 |
4 | 4 (0%) | 3 (0%) | 1 (1%) | 1.000 |
Negative in serotyping | 386 (48%) | 296 (46%) | 90 (56%) | 0.022 |
One serotype detected | 283 (35%) | 233 (36%) | 50 (31%) | 0.268 |
Two serotypes detected | 111 (14%) | 93 (14%) | 18 (6%) | 0.370 |
> 3 serotypes detected | 29 (4%) | 26 (4%) | 3 (2%) | 0.240 |